Viatris (VTRS) Cash from Operations (2019 - 2026)
Viatris (VTRS) posted quarterly Cash from Operations of 388300000.0 for Q1 2026, down 27.49% year-over-year from 535500000.0 in Q1 2025, and down 52.4% quarter-over-quarter from 815800000.0 in Q4 2025.
Viatris (VTRS) Cash from Operations (2019 - 2026) Analysis & Trends
Viatris' Cash from Operations history runs 8 years deep, the most recent figure standing at 388300000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 27.49% year-over-year to 388300000.0; the TTM figure through Mar 2026 stood at 2168700000.0 (down 2.48% YoY), while the FY2025 annual figure was 2315900000.0, up 0.56% from the prior year.
- Cash from Operations for Q1 2026 stood at 388300000.0, down from 815800000.0 in the prior quarter.
- The five-year high for Cash from Operations was 1138500000.0 in Q1 2022, with the low at 189000000.0 in Q4 2022.
- The 5-year median for Cash from Operations is 614600000.0 (2024), against an average of 641535294.12.
- The sharpest annual moves came in 2022 and 2023: Cash from Operations plunged 63.87% in 2022, then surged 200.79% in 2023.
- Viatris' Cash from Operations stood at 189000000.0 in 2022, then soared by 200.79% to 568500000.0 in 2023, then dropped by 15.09% to 482700000.0 in 2024, then surged by 69.01% to 815800000.0 in 2025, then tumbled by 52.4% to 388300000.0 in 2026.
- Business Quant data shows VTRS's Cash from Operations at 388300000.0 in Q1 2026, 815800000.0 in Q4 2025, and 744900000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.09 Bn | 7.43 Bn | 397.90 Mn | 145.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 381.80 Mn |
| Jun 30, 2026 | 381.80 Mn |
| Mar 31, 2026 | 388.30 Mn |
| Mar 31, 2026 | 388.30 Mn |
| Dec 31, 2025 | 815.80 Mn |
| Dec 31, 2025 | 815.80 Mn |
| Sep 30, 2025 | 744.90 Mn |
| Sep 30, 2025 | 744.90 Mn |
| Jun 30, 2025 | 219.70 Mn |
| Jun 30, 2025 | 219.70 Mn |
| Mar 31, 2025 | 535.50 Mn |
| Mar 31, 2025 | 535.50 Mn |
| Dec 31, 2024 | 482.70 Mn |
| Dec 31, 2024 | 482.70 Mn |
| Sep 30, 2024 | 826.50 Mn |
| Sep 30, 2024 | 826.50 Mn |
| Jun 30, 2024 | 379.10 Mn |
| Jun 30, 2024 | 379.10 Mn |
| Mar 31, 2024 | 614.60 Mn |
| Mar 31, 2024 | 614.60 Mn |